-
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing
en-cphi.cn
March 12, 2019
InventisBio Inc., a clinical stage biotech company, announced the closing of a $70 million USD Series C financing in January 2019.
-
Semma Therapeutics appoints new President
biospectrumasia
May 15, 2018
Dr. Sanna will succeed Elizabeth Stoner who has been serving as the Interim CEO and will remain as an advisor to the Company
-
Innovent secures funding worth $150M
biospectrumasia
May 02, 2018
The proceeds will be used to speed up and expand the company's clinical programs.
-
Europe's biggest private biotech company raises $270 million
en-cphi.cn
February 06, 2018
BioNTech has raised $270 million to support its work in developing personalized immunotherapies for cancer, ahead of an expected eventual stock market flotation.
-
Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs
biospace
January 29, 2018
It’s a common and accepted business practice for venture capital firms to invest in biotech companies, often running those companies until they get to a point where they can be acquired or partnered
-
Why This Mostly-Unheard of Colorado Biotech Could Hit $1B in Revenue by 2025
biospace
January 17, 2018
Leah Rush Cann, an analyst with Oppenheimer, launched coverage of miRagen, a little-known biotech company, citing the possibility it could exceed $1.2 billion in revenue by 2025.